Advisory - Health Canada advises consumers not to use four unauthorized natural health products that claim to treat serious diseases

OTTAWA, Nov. 2 /CNW Telbec/ - Health Canada is advising consumers not to
use four unauthorized natural health products that are promoted to treat
serious health conditions such as cancer, arthritis and heart disease because
such unapproved health claims are in violation of the Food and Drugs Act.
These unproven health claims may mislead patients to use the unauthorized
products in place of proven, approved treatment.

Although these products - Ellagimax capsules, Coral Max capsules, Coral
Max without Iron capsules, and Advanced Arthritis Support capsules - are
labelled as dietary supplements, they are being promoted with claims typically
associated with drug products. These claims are evident in the products'
labelling and promotional material. The safety and effectiveness of these
products have not been proven.

Ellagimax, Coral Max, Coral Max without Iron and Advanced Arthritis
Support capsules are distributed by Advantage Nutraceuticals L.L.C. of Fort
Walton Beach, Florida. They are not authorized for sale in Canada and have not
been found in the Canadian marketplace. However, the products have been sold
over the Internet and may also have been brought into Canada for personal use
by travellers.

Health Canada also advises Canadians to contact the Health Products and
Food Branch Inspectorate at 1-800-267-9675 if they find any of these four
products for sale in Canada. Health Canada has notified Customs officials to
be on the lookout for these products.

Canadians who have used any of these products and are concerned about
their health should contact a health care practitioner for advice. To date, no
adverse reactions suspected to be associated with the use of these four
products have been reported to Health Canada.

Consumers requiring more information about this advisory can contact the
Health Canada public inquiries line at (613) 957-2991, or toll free at

To report a suspected adverse reaction to these or any other health
products, please contact the Canadian Adverse Drug Reaction Monitoring Program
(CADRMP) of Health Canada by one of the following methods:

Telephone: 1-866-234-2345
Facsimile: 1-866-678-6789

Marketed Health Products Directorate
Tunney's Pasture, AL 0701C
email: [email protected]

The CADRMP adverse reaction reporting form, including a version that can
be completed and submitted online, is located on the MedEffect portal
( of the Health Canada Web site.

Egalement disponible en français

For further information: Media Inquiries: Health Canada, (613) 957-2983;
Public Inquiries: (613) 957-2991, 1-866-225-0

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.